Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

October 01, 2007 (Vol. 27, No. 17)

Biomarket Trends: Four Therapies Dominate MS Treatment

Overwhelming Unmet Need Has Created Significant Growth Potential for Drugs

  • An estimated 2.5 million people suffer from multiple sclerosis (MS) worldwide—less than 0.04% of the global population. However, the epidemiology of the disease appears to be undergoing dramatic changes, and so are the approaches that pharmaceutical researchers and marketers are taking. Multiple sclerosis is one of the most common ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.